Danaher Corporation

$196.71
(as of May 1, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Danaher Corporation

Stock Price
$196.71
Ticker Symbol
DHR
Exchange
NYSE

Industry Information for Danaher Corporation

Sector
Healthcare
Industry
Diagnostics & Research

Company Description for Danaher Corporation

Country
USA
Full Time Employees
61,000

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.

Fundamentals for Danaher Corporation

Market Capitalization
$142,654,504,960
EBITDA
$7,464,000,000
Dividends per Share
$1.13
P/E Ratio
38.7
Forward P/E Ratio
26.39
Earnings per Share
$5.15
Earnings per Share Estimate Next Year
Profit Margin
15.81%
Shares Outstanding
715,670,016
Percent Owned by Insiders
11.04%
Percent Owned by Institutions
82.07%
52-Week High
52-Week Low

Technical Indicators for Danaher Corporation

50-Day Moving Average
200-Day Moving Average
RSI
50.3
7.14

Analyst Ratings for Danaher Corporation

Strong Buy
18
Buy
5
Hold
4
Sell
0
Strong Sell
0

News About Danaher Corporation

May 1, 2025, 2:26 PM EST
We recently published an article titled Charles Akre's and John Neff's 10 Stock Picks with Huge Upside Potential. See more.
Apr 29, 2025, 10:07 AM EST
Kytopen and Aldevron announce collaboration to expedite cell therapy manufacturing by combining their novel technologies. See more.
Apr 29, 2025, 8:25 AM EST
We recently published a list of Jim Cramer Talks About Elon Musk & Discusses These 11 Stocks. See more.
Apr 28, 2025, 8:16 AM EST
We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. See more.